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Abstract 
Based on the abundance of specific bacterial genera, the human gut microbiota can be divided into two 
relatively stable groups that might play a role in personalized nutrition. We studied these simplified 
enterotypes as prognostic markers for successful body fat loss on two different diets. A total of 62 
participants with increased waist circumference were randomly assigned to receive an ad libitum New 
Nordic Diet (NND) high in fiber/wholegrain or an Average Danish Diet (ADD) for 26 weeks. 
Participants were grouped into two discrete enterotypes by their relative abundance of Prevotella spp. 
divided by Bacteroides spp. (P/B ratio) obtained by quantitative PCR analysis. Modifications of dietary 
effects of pre-treatment P/B group were examined by linear mixed models. Among individuals with 
high P/B the NND resulted in a 3.15 kg (95%CI 1.55;4.76, P<0.001) larger body fat loss compared to 
ADD whereas no differences was observed among individuals with low P/B (0.88 kg [95% CI -
0.61;2.37, P=0.25]). Consequently, a 2.27 kg (95%CI 0.09;4.45, P=0.041) difference in responsiveness 
to the diets were found between the two groups. In summary, subjects with high P/B-ratio appeared 
more susceptible to lose body fat on diets high in fiber and wholegrain than subjects with a low P/B-
ratio.  
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Introduction 
The composition of the gut microbiota in rodents has been shown to affect the efficacy of energy 
harvest from feed (1) and to influence the secretion of gastrointestinal hormones affecting appetite (2). 
Therefore, it seems as if the human gut microbiota has the potential to play a pivotal role in 
personalized nutrition (3, 4). 
Clustering of the human gut microbiota, designated enterotypes, was first described in 2011 (5). 
The Bacteroides-driven enterotype is reported to be predominant in individuals consuming more 
protein and animal fat (western diet), whereas the Prevotella-driven enterotype appears predominant in 
subjects consuming more carbohydrate and fiber (6-8). That said, the enterotype of an individual has 
been shown to remain rather stable (6, 7, 9). A limited number of studies have related microbial 
enterotypes to health markers (8-10); however, body fat change during a randomized clinical trial is not 
one of them. 
Therefore, as a proxy for enterotypes, we studied pre-treatment Prevotella/Bacteroides (P/B) 
ratio as a prognostic marker for successful body fat loss on two diets differing greatly in dietary fiber 
and wholegrain content. 
 
Methods 
In total 181 participants with increased waist circumference were randomly assigned to receive an ad 
libitum New Nordic Diet (NND) or a control diet for 26 weeks of which a subgroup of 62 subjects were 
randomized to collect fecal samples. The macronutrient composition of the NND was based on Nordic 
Nutrition Recommendations, whereas the control diet was designed to match the macronutrient 
composition of an Average Danish Diet (ADD) (11). The NND is a whole food approach characterized 
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by being very high in dietary fiber, wholegrain, fruit, and vegetables (12). For both groups, food and 
beverages were provided from a study shop free of charge throughout the intervention period (12). Pre-
intervention fasting blood samples were drawn from where fasting glucose and insulin were analyzed. 
Height was measured at baseline and body weight was measured at randomization and week 2, 4, 8, 12, 
16, 20, 24, and 26. Furthermore, waist circumference and fat mass (using DEXA) were measured at 
randomization, week 12 and 26. Fecal samples were collected at baseline and the relative abundance of 
Prevotella spp. and Bacteroides spp. was determined using genera-specific quantitative PCR targeting 
the bacterial 16S ribosomal gene regions as previously described (9). As previously reported by Roager 
et al. (9), this resulted in a clear bi-modal separation of subjects based on the log Prevotella spp. to 
Bacteroides spp. ratio, in the following designated low P/B (<0.01) or high P/B (>0.01). In eight 
samples, Prevotella spp. was below the detection limit and were classified as low P/B in the main 
analysis and excluded in a sensitivity analysis. Regardless of randomization status, after the completion 
of the first 26 weeks all participants were instructed to follow the NND for an additional year (weight 
measured after 52 and 78 weeks) without any provision of food (13) to investigate the diets in a real 
life setting. The study was approved by the ethical committee of the Capital Region of Denmark 
(reference H-3-2010-058) and registered at clinicaltrials.gov as NCT01195610. 
 
Statistics 
Baseline characteristics were summarized as mean ± standard deviation, median (interquartile range) or 
proportions (%) and differences between P/B groups as well as dietary groups were tested using a 
parametric (variables possibly transformed before analysis) or non-parametric two-sample test or 
Pearson’s chi-squared test. 
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The differences in body fat (as well as weight and waist circumference) change from baseline 
between enterotypes on the two diets were analyzed by means of linear mixed models using all 
available measurements. The linear mixed models included the three-way interaction between diet x 
time x P/B group strata as well as all nested two-way interactions and main effects and comprised 
additional fixed effects including age, gender, baseline BMI, baseline fasting glucose and insulin as 
well as random effects for subjects. Results are shown as mean change from baseline with 95% 
confidence interval (CI). The level of significance was set at P<0.05 and statistical analyses were 
conducted using STATA/SE 14.1 (Houston, USA). 
 
Results  
The NND compared to ADD was higher in dietary fibre (43.3 vs. 28.6 g/10MJ), higher in protein (18.1 
vs. 16.4%), lower in fat (30.4 vs. 33.8%) (all P<0.001) without differing in available carbohydrates 
(46.4 vs. 45.3%; P=0.081). 
No differences in baseline characteristics were found between individuals characterized as high 
and low P/B (all P≥0.09) (Table 1). Among individuals with a high P/B ratio, the NND diet resulted in 
a 3.15 kg (95%CI 1.55;4.76, P<0.001) larger body fat loss compared to ADD after 26 weeks while no  
difference in body fat loss was observed between NND and ADD among individuals with low P/B 
(0.88 kg [95%CI -0.61;2.37, P=0.25]). Consequently, a 2.27 kg (95%CI 0.09;4.45, P=0.041) difference 
in responsiveness to the diets was found between the P/B groups which came from difference in 
response to NND (P=0.04) and not ADD (P=0.41) between the P/B groups (Table 2). Similar 
differences in responsiveness to the diets were found for waist circumference (3.95 cm [95%CI 
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0.34;7.55, P=0.032])  and were borderline significant for body weight (2.33 kg [95% CI -0.15;4.80, 
P=0.065]) (Table 2). The sensitivity analysis revealed larger differences (Table 2). 
During the one year follow-up period, subjects with the high P/B ratio changing from ADD to 
being recommended NND maintained their weight [-1.23 (95% CI -2.81;0.36, n=9, P=0.13)], whereas 
subjects with the low P/B ratio changing from ADD to being recommended NND regained 2.76 kg 
(95% CI 1.27;4.24, n=11, P<0.001). Consequently, a 3.99 kg (95% CI, 1.82;6.15, P<0.001) difference 
in responsiveness to the NND were found between P/B groups during the one year follow-up. This 
difference was 5.41 kg (95% CI 3.12;7.69, P<0.001) in the sensitivity analysis. 
 
Discussion 
We identified pre-treatment P/B ratio as an important biomarker associated with body fat loss in 
subjects consuming an ad libitum diet rich in fiber and wholegrain. Thus, overweight and obese 
participants with high P/B ratio appeared more responsive to fiber and wholegrain than individuals with 
low P/B ratio. This was further supported by similar findings for waist circumference and body weight.  
Using the entire sample of 181 subjects, we have previously reported the overall weight loss 
difference between the NND and ADD to be 3.2 kg (12). Interestingly, this difference between diets 
could mainly be attributed to subjects with the high P/B ratio, and the health promoting aspects of the 
NND in terms of body weight regulation therefore mainly seems to apply in a subset of the population.  
Previously, baseline total cholesterol has been found to be borderline higher (P=0.08) (9) and 
LDL cholesterol to be lower (8) among the Prevotella-driven enterotype. Furthermore, the enterotypes 
have been found to impact in vitro fermentation profiles of short chain fatty acids from the same 
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carbohydrate substrates differentially, with the Prevotella-driven enterotype having higher total short 
chain fatty acid production (3). In vitro, some of these short chain fatty acids have been shown to 
stimulate the secretions of gastrointestinal hormones affecting appetite (2). Finally, in an observational 
study of 1632 women, the abundance of Bacteroides spp. was associated with weight gain, while 
dietary fiber intake was found partly to modify the association between microbiome diversity and 
weight gain (14). 
The distinction of enterotypes as discrete clusters has recently been challenged by studies 
suggesting that enterotype distribution is continuous and that further information may be masked 
within these enterotype clusters (15, 16). From our analysis we cannot determine specific bacterial 
species responsible for the dietary effects that we observe but only highlight the relative abundance of 
Prevotella spp. (genus) as important in the classification of microbiota profiles. Nevertheless our 
sensitivity analysis indicates that subjects with Prevotella spp. below the detection limit behave 
different than subjects in the low P/B ratio group. 
The increased responsiveness of the high P/B group to the NND, rich in fruits, vegetables and 
whole grains, is supported by previous studies showing an association between the Prevotella-driven 
enterotype and a carbohydrate-based diet more typical of agrarian societies (6). However, only two 
individuals switched P/B ratio group during this 6 month dietary intervention with NND or ADD (9), 
which is consistent with the literature indicating that intestinal microbial communities are resilient and 
difficult to change through dietary interventions (6, 7, 9) unless extreme changes, such as complete 
removal of carbohydrates from the diet, are introduced (17). 
Mechanisms involved could be efficacy of energy harvest from different foods (1), differences 
in fibre-utilization capacity (3), gut-brain signalling of behaviour (18), and the secretion of 
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gastrointestinal hormones affecting appetite (2, 10). Recently, dietary fiber-induced improvements in 
post-prandial blood glucose and insulin were found to be positively associated with the abundance of 
Prevotella (19). Therefore, the recent breakthrough in personalized nutrition, showing the importance 
of pre-treatment fasting glucose and insulin to determine the optimal diet for weight management (20), 
might also be linked to gut microbiota profiles. We therefore adjusted for a number of potential 
confounders including fasting glucose and insulin. However, independent of the mechanisms, the P/B 
ratio may serve as a biomarker to predict future weight loss success on specific diets.  
In summary, we identified pre-treatment P/B ratio as an important biomarker associated with 
dietary body fat change on ad libitum high fiber diets. Thus, individuals with a high P/B ratio were 
more susceptible to body fat loss on a diet rich in fiber and whole grain compared to an average Danish 
diet, whereas no difference in body fat loss was observed in individuals with a low P/B ratio.  
©    2017 Macmillan Publishers Limited. All rights reserved.
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Table 1: Baseline characteristics of the study populations stratified by enterotype (n=62) 
 High P/B group (n=28) Low P/B group (n=34) P-value 
Age (year) 41.9 (30.4;56.7) 47.5 (33.0;55.6) 0.33 
Gender (%female / male) 64.3 /35.7 69.2 /30.8 0.70 
Body weight (kg) 91.6 ±17.6 84.8±16.0 0.12 
Body mass index (kg/m
2
) 31.0±4.7 29.0±4.4  0.09 
Body fat (%) 40.5±6.4 38.9±7.1 0.36 
Fasting glucose (mmol/L) 5.34±0.51 5.19±0.40 0.20 
Fasting insulin (pmol/L) 54.5 (41;78) 47.5 (35;74) 0.14 
Prevotella spp (relative abundance) 0.016 (0.008;0.063) 0.00002 (0.000003;0.00005) <0.001
1 
Bacteroides (relative abundance) 0.07 (0.05;0.11) 0.17 (0.10;0.26) <0.001
1 
Prevotella-to-Bacteroides ratio 0.28 (0.11;7.50) 0.00007 (0.00001;0.00026)  
Abbreviation: P/B, Prevotella-to-Bacteroides ratio. Data are presented as mean ± standard deviation, 
median (interquartile range) or proportions (%) and differences between enterotypes were tested using a 
two-sample t-test (variables possibly transformed before analysis) or Pearson’s chi-squared test. 
1
Using the non-parametric two-sample Wilcoxon rank-sum (Mann-Whitney) test.  
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Table 2: Changes in body fat, body weight and waist circumference after 26 weeks on NND and ADD among high P/B and low P/B groups. 
 High P/B group Low P/B group 
   
 
∆(NND-ADD) in high P/B  -   
∆(NND-ADD) in low P/B 
All Subjects NND (n=15) ADD (n=13) NND (n=21) ADD (n=13) P
1
 P
2
 P
3
 P
4 
 P
5 
∆Body fat (kg) -4.97 (-6.06;-3.88) -1.82 (-3.01;-0.63) -3.41 (-4.35;-2.48) -2.53 (-3.69;-1.37) <0.001 0.25 0.04 0.41 -2.27 (-4.45;-0.09) 0.041 
∆Weight (kg) -4.58 (-5.82;-3.34) -1.09 (-2.43;0.25) -3.27 (-4.33;-2.22) -2.11 (-3.43;-0.79) <0.001 0.18 0.12 0.29 -2.33 (-4.80;0.15) 0.065 
∆WC (cm) -5.19 (-6.99;-3.38)
 
-0.44 (-2.41;1.52)
 
-3.09 (-4.64;-1.55)
 
-2.29 (-4.22;-0.37)
 
<0.001 0.53 0.09 0.19 -3.95 (-7.55;-0.34) 0.032 
Sensitivity
6
 
 
NND (n=15) ADD (n=13) NND (n=16) ADD (n=10) P
1
 P
2
 P
3
 P
4
  P
5
 
∆Body fat (kg) -4.96 (-5.95;-3.97) -1.79 (-2.87;-0.71) -2.94 (-3.93;-1.94) -2.71 (-3.92;-1.50) <0.001 0.78 0.01 0.27 -2.94 (-5.05;-0.85) 0.006 
∆Weight (kg) -4.57 (-5.70;-3.45) -1.07 (-2.29;0.15) -2.52 (-3.64;-1.40) -2.56 (-3.93;-1.18) <0.001 0.97 0.01 0.12 -3.53 (-5.92;-1.15) 0.004 
∆WC (cm) -5.14 (-6.91;-3.36) -0.54 (-2.47;1.39) -2.29 (-4.07;-0.52) -3.60 (-5.76;-1.43) <0.001 0.36 0.03 0.04 -5.90 (-9.65;-2.14) 0.002 
Abbreviations: ADD, Average Danish Diet; New Nordic Diet; P/B, Prevotella-to-Bacteroides ratio; WC, Waist circumference. Data are presented as estimated 
mean body fat, body weight and waist circumference change from baseline and 95% confidence intervals for each combination of the diet-enterotype strata 
interaction after 26 weeks in the linear mixed models, which were additionally adjusted for age, gender, baseline BMI, fasting glucose and insulin as well as 
random effects for subjects.  
1 
P-value representing the difference in dietary response within the high P/B group. 
2 
P-value representing the difference in dietary response within the low P/B group. 
3 
P-value representing the difference in response to NND between the P/B groups. 
4 
P-value representing the difference in response to ADD between the P/B groups. 
5 
P-value representing the following pairwise comparison using post hoc t-tests: ∆(NND-ADD) among subjects with high P/B minus ∆(NND-ADD) among subjects 
with low P/B. 
6
 Sensitivity analyses excluding the eight subjects with Prevotella spp. below the detection limit. 
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